Mesa Laboratories, Inc. (MLAB)

Mesa Laboratories Financials Overview

Financials in millions USD. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	251.32	249.13	240.98	216.19	219.08	184.34
Revenue Growth	2.48%	3.38%	11.47%	-1.32%	18.85%	37.63%
Gross Profit Gross Profit Growth	162.89	158.27	152.1	134.48	133.69	109.09
Operating Income Operating Income Growth	26.14	18.51	17.57	3.69	3.32	4.7
Net Income Net Income Growth	6.67	6.71	-1.97	-254.25	0.93	1.87
Earnings Per Share EPS Growth	1.18	1.21	-0.36	-47.20	0.17	0.35
EPS Growth	-	-	-	-	-51.43%	-45.31%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Sterilization and Disinfection Control Sterilization and Disinfection Control Growth	103.9	101.57	93.42	75.12	64.61	59.04
Biopharmaceutical Development Biopharmaceutical Development Growth	48.06	48.63	48.73	40.71	47.37	45.58
Calibration Solutions Calibration Solutions Growth	54.97	53.55	51.75	47.76	44.81	46.87
Clinical Genomics Clinical Genomics Growth	44.4	45.39	47.08	52.59	62.3	32.84
Total Total Growth	251.32	249.13	240.98	216.19	219.08	184.34

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	23.95	28.57	29.07	30.11	32.91	49.35
Total Debt Total Debt Growth	149.5	168.83	193.85	231.3	191.89	228.57
Net Cash (Debt) Net Cash Growth	-125.56	-140.26	-164.78	-201.19	-158.98	-179.22
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-22.20	-25.20	-30.40	-37.35	-29.66	-33.59

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	51.55	42.83	46.81	44.13	27.98	39.22
Capital Expenditures CapEx Growth	-2.1	-3.25	-4.25	-2.57	-4.54	-4.43
Free Cash Flow Free Cash Flow Growth	49.45	39.58	42.56	41.57	23.44	34.79
Free Cash Flow Growth	32.80%	-7.00%	2.39%	77.34%	-32.63%	-0.83%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	64.81%	63.53%	63.12%	62.20%	61.02%	59.18%
Operating Margin	10.40%	7.43%	7.29%	1.70%	1.52%	2.55%
Pretax Margin	5.33%	4.82%	2.47%	-127.50%	-0.18%	1.94%
Profit Margin	2.65%	2.69%	-0.82%	-117.61%	0.43%	1.01%
FCF Margin	19.68%	15.89%	17.66%	19.23%	10.70%	18.87%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	0.640	0.640	0.640	0.640	0.640	0.640
Dividend Per Share Growth	0%	0%	0%	0%	0%	0%
Dividend Yield	0.45%	0.72%	0.54%	0.58%	0.37%	0.25%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	120.16	72.78	-	-	1004.45	714.64
Forward PE	48.95	63.76	16.50	17.53	27.40	39.18
P/FCF Ratio	16.10	12.34	15.15	14.24	39.85	38.43
PS Ratio	3.17	1.96	2.68	2.74	4.26	7.25

Data Source: S&P Global Market Intelligence Last updated: Nov 9, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error